17-75834443-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BS1_Supporting
The NM_199242.3(UNC13D):c.2180G>A(p.Arg727Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000259 in 1,565,778 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_199242.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152252Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000439 AC: 76AN: 173178Hom.: 1 AF XY: 0.000424 AC XY: 40AN XY: 94334
GnomAD4 exome AF: 0.000269 AC: 380AN: 1413408Hom.: 0 Cov.: 33 AF XY: 0.000293 AC XY: 205AN XY: 700226
GnomAD4 genome AF: 0.000171 AC: 26AN: 152370Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74508
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: UNC13D c.2180G>A (p.Arg727Gln) results in a conservative amino acid change located in the MUN domain (IPR010439) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00044 in 173178 control chromosomes, predominantly at a frequency of 0.0015 within the South Asian subpopulation in the gnomAD database, including 1 homozygotes. This frequency is not significantly higher than estimated for a pathogenic variant in UNC13D causing Familial Hemophagocytic Lymphohistiocytosis (0.00044 vs 0.0027), allowing no conclusion about variant significance. c.2180G>A has been reported in the literature in either the compound heterozygous or heterozygous state in individuals affected with Familial Hemophagocytic Lymphohistiocytosis or other immune dysregulation disorders, without strong evidence for causality (e.g. Sieni_2011, Batlle-Maso_2020, Xinh_2021, Allain_2023) . These reports do not provide unequivocal conclusions about association of the variant with Familial Hemophagocytic Lymphohistiocytosis. At least one publication reports experimental evidence evaluating an impact on protein function (Shibata_2018). These results suggested the variant may have mild to moderately reduced stability, but showed no damaging effect on degranulation and cytolytic activity in vitro and was capable of restoring the degranulation and cytolytic activity of a familial hemophagocytic lymphohistiocytosis cell line to levels comparable with cells transfected with the WT protein. The following publications have been ascertained in the context of this evaluation (PMID: 36155879, 32222431, 29549174, 21248318, 34339548). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as either uncertain significance or likely benign. Based on the evidence outlined above, the variant was classified as VUS-possibly benign. -
Autoinflammatory syndrome Uncertain:1
- -
Familial hemophagocytic lymphohistiocytosis 3 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at